Clinical Trial Update: Adjuvant Aflibercept for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of adjuvant aflibercept for metastatic colorectal cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Brown University | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-03-10